A pooled analysis of 655 patients with advanced melanoma enrolled in KEYNOTE-001: long-term efficacy of pembrolizumab (MK-3475)

A. Daud; A. M. Joshua; A. Ribas; C. Robert; F. S. Hodi; J. Wolchok; W-J Hwu; J. S. Weber; T. C. Gangadhar; R. Joseph; R. Dronca; A. Patnaik; H. Zarour; R. Kefford; J. Lindia; X. N. Li; S. Ebbinghaus; S. P. Kang; O. Hamid

A pooled analysis of 655 patients with advanced melanoma enrolled in KEYNOTE-001: long-term efficacy of pembrolizumab (MK-3475)

A. Daud, A. M. Joshua, A. Ribas, C. Robert, F. S. Hodi, J. Wolchok, W-J Hwu, J. S. Weber, T. C. Gangadhar, R. Joseph, R. Dronca, A. Patnaik, H. Zarour, R. Kefford, J. Lindia, X. N. Li, S. Ebbinghaus, S. P. Kang, O. Hamid

Faculty of Medicine, Health and Human Sciences

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	43
Number of pages	1
Journal	Asia-Pacific Journal of Clinical Oncology
Volume	11
Publication status	Published - Aug 2015

Cite this

Daud, A., Joshua, A. M., Ribas, A., Robert, C., Hodi, F. S., Wolchok, J., Hwu, W.-J., Weber, J. S., Gangadhar, T. C., Joseph, R., Dronca, R., Patnaik, A., Zarour, H., Kefford, R., Lindia, J., Li, X. N., Ebbinghaus, S., Kang, S. P., & Hamid, O. (2015). A pooled analysis of 655 patients with advanced melanoma enrolled in KEYNOTE-001: long-term efficacy of pembrolizumab (MK-3475). Asia-Pacific Journal of Clinical Oncology, 11, 43.

@article{40242b5a0448497e96d478e9954dc805,

title = "A pooled analysis of 655 patients with advanced melanoma enrolled in KEYNOTE-001: long-term efficacy of pembrolizumab (MK-3475)",

author = "A. Daud and Joshua, {A. M.} and A. Ribas and C. Robert and Hodi, {F. S.} and J. Wolchok and W-J Hwu and Weber, {J. S.} and Gangadhar, {T. C.} and R. Joseph and R. Dronca and A. Patnaik and H. Zarour and R. Kefford and J. Lindia and Li, {X. N.} and S. Ebbinghaus and Kang, {S. P.} and O. Hamid",

year = "2015",

month = aug,

language = "English",

volume = "11",

pages = "43",

journal = "Asia-Pacific Journal of Clinical Oncology",

issn = "1743-7555",

publisher = "Wiley-Blackwell, Wiley",

}

Daud, A, Joshua, AM, Ribas, A, Robert, C, Hodi, FS, Wolchok, J, Hwu, W-J, Weber, JS, Gangadhar, TC, Joseph, R, Dronca, R, Patnaik, A, Zarour, H, Kefford, R, Lindia, J, Li, XN, Ebbinghaus, S, Kang, SP & Hamid, O 2015, 'A pooled analysis of 655 patients with advanced melanoma enrolled in KEYNOTE-001: long-term efficacy of pembrolizumab (MK-3475)', Asia-Pacific Journal of Clinical Oncology, vol. 11, pp. 43.

TY - JOUR

T1 - A pooled analysis of 655 patients with advanced melanoma enrolled in KEYNOTE-001

T2 - long-term efficacy of pembrolizumab (MK-3475)

AU - Daud, A.

AU - Joshua, A. M.

AU - Ribas, A.

AU - Robert, C.

AU - Hodi, F. S.

AU - Wolchok, J.

AU - Hwu, W-J

AU - Weber, J. S.

AU - Gangadhar, T. C.

AU - Joseph, R.

AU - Dronca, R.

AU - Patnaik, A.

AU - Zarour, H.

AU - Kefford, R.

AU - Lindia, J.

AU - Li, X. N.

AU - Ebbinghaus, S.

AU - Kang, S. P.

AU - Hamid, O.

PY - 2015/8

Y1 - 2015/8

UR - https://doi.org/10.1111/ajco.12396

M3 - Meeting abstract

SN - 1743-7555

VL - 11

SP - 43

JO - Asia-Pacific Journal of Clinical Oncology

JF - Asia-Pacific Journal of Clinical Oncology

ER -

A pooled analysis of 655 patients with advanced melanoma enrolled in KEYNOTE-001: long-term efficacy of pembrolizumab (MK-3475)

Other files and links

Cite this